TAp63 regulates oncogenic miR-155 to mediate migration and tumour growth

por Mattiske, Sam, Ho, Kristen, Noll, Jacqueline E., Neilsen, Paul M., Callen, David F., Suetani, Rachel J.
Publicado 2013

SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma()()

por Noll, Jacqueline E., Hewett, Duncan R., Williams, Sharon A., Vandyke, Kate, Kok, Chung, To, Luen B., Zannettino, Andrew C.W.
Publicado 2014

GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice

por Friend, Natasha, Noll, Jacqueline E., Opperman, Khatora S., Clark, Kimberley C., Mrozik, Krzysztof M., Vandyke, Kate, Hewett, Duncan R., Zannettino, Andrew C. W.
Publicado 2020

Characterization of the role of Samsn1 loss in multiple myeloma development

por Friend, Natasha L., Hewett, Duncan R., Panagopoulos, Vasilios, Noll, Jacqueline E., Vandyke, Kate, Mrozik, Krzysztof M., Fitter, Stephen, Zannettino, Andrew C.W.
Publicado 2020

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

por Neilsen, Paul M., Noll, Jacqueline E., Suetani, Rachel J., Schulz, Renee B., Al-Ejeh, Fares, Evdokiou, Andreas, Lane, David P., Callen, David F.
Publicado 2011

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

por Noll, Jacqueline E., Vandyke, Kate, Hewett, Duncan R., Mrozik, Krzysztof M., Bala, Rachel J., Williams, Sharon A., Kok, Chung H., Zannettino, Andrew CW
Publicado 2015

DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment

por Hewett, Duncan R., Vandyke, Kate, Lawrence, David M., Friend, Natasha, Noll, Jacqueline E., Geoghegan, Joel M., Croucher, Peter I., Zannettino, Andrew C.W.
Publicado 2017

Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma

por Bradey, Alanah L., Fitter, Stephen, Duggan, Jvaughn, Wilczek, Vicki, Williams, Connor M. D., Cheney, Emma AJ., Noll, Jacqueline E., Tangseefa, Pawanrat, Panagopoulos, Vasilios, Zannettino, Andrew C. W.
Publicado 2022

LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib

por Mrozik, Krzysztof M., Cheong, Chee M., Hewett, Duncan R., Noll, Jacqueline E., Opperman, Khatora S., Adwal, Alaknanda, Russell, Darryl L., Blaschuk, Orest W., Vandyke, Kate, Zannettino, Andrew C. W.
Publicado 2020

Clodronate-Liposome Mediated Macrophage Depletion Abrogates Multiple Myeloma Tumor Establishment In Vivo

por Opperman, Khatora S., Vandyke, Kate, Clark, Kimberley C., Coulter, Elizabeth A., Hewett, Duncan R., Mrozik, Krzysztof M., Schwarz, Nisha, Evdokiou, Andreas, Croucher, Peter I, Psaltis, Peter J, Noll, Jacqueline E, Zannettino, Andrew CW
Publicado 2019